Atlas Trials

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

Clinical trial NCT03490201 · COMPLETED

Trial details

NCT number
NCT03490201
Sponsor
Abbott Medical Devices
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Ventricular Tachycardia
Start date
2018-06-01
Primary completion
2024-04-11
Enrollment
592

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.